Remedy · drug
Empagliflozin
Also: Synjardy
A SGLT2 inhibitor antidiabetic drug.
Evidence by condition
Each grade reflects the research for Empagliflozin and that condition specifically.
No graded conditions recorded yet.
Empagliflozin is a SGLT2 inhibitor antidiabetic drug. This is a reference stub — its uses and interactions are not yet curated here.
Source: U.S. FDA drug labeling via openFDA (public domain).